USA – FDA: Nearly All Essure Devices Returned to Bayer, Enrollment in Postmarket Study Complete

In the latest update in the years-long investigation into the safety of Bayer’s permanent birth control device Essure, the US Food and Drug Administration (FDA) on Friday said that nearly all unused Essure devices have been returned to Bayer and that the company has wrapped up enrollment in an FDA-mandated postmarketing study.
 
Since Bayer announced it would stop marketing and distributing the devices in the US in July 2018, the company has sought to collect all remaining unused Essure devices from its customers. Bayer pulled Essure from international markets in September 2017…